Opinion: Blue blood on the streets

If Lloyd's aggregate results were not already shock enough,
yesterday'sexclusive revelation that MS Amlin was a £1.4bn ($2bn)
capacity outlier within that £33bn whole ripped down Lime
Street like a lightning bolt.
Amlin was one of the jewels in the crown. It was market royalty.
A high-teens return business with potential for global growth. A
consistently top-quartile performer and a respected leader. The
first name on the team sheet and probably the last on the
Lloyd's performance di